Michael Wegmann Selected Research

Michael Wegmann Research Topics

Disease

30	Asthma (Bronchial Asthma) 09/2023 - 08/2004
19	Inflammation (Inflammations) 09/2023 - 08/2004
9	Respiratory Hypersensitivity 01/2019 - 08/2004
5	Hypersensitivity (Allergy) 01/2014 - 08/2004
3	Infections 01/2022 - 08/2006
3	Hyperplasia 01/2014 - 04/2005
2	Virus Diseases (Viral Diseases) 07/2020 - 06/2007
2	Eosinophilia 01/2016 - 01/2009
2	Immediate Hypersensitivity 03/2010 - 10/2009
2	Airway Remodeling 02/2008 - 01/2007
1	Lung Diseases (Lung Disease) 01/2022
1	Cystic Fibrosis (Mucoviscidosis) 12/2021
1	Fibrosis (Cirrhosis) 12/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019
1	Peritonitis 01/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 07/2015
1	Emphysema 07/2015
1	Allergic Rhinitis 01/2014
1	Rhinitis 01/2014
1	Body Weight (Weight, Body) 01/2012
1	Heartburn (Pyrosis) 04/2007

Drug/Important Bio-Agent (IBA)

13	CytokinesIBA 01/2022 - 08/2006
9	AllergensIBA 09/2023 - 08/2004
8	OvalbuminIBA 01/2021 - 01/2007
7	Immunoglobulin E (IgE)IBA 01/2012 - 06/2007
4	AerosolsIBA 01/2019 - 01/2007
3	Interleukin-17 (Interleukin 17)IBA 01/2022 - 06/2015
3	Interleukin-1 (Interleukin 1)IBA 01/2022 - 01/2015
3	Interleukin-13IBA 01/2014 - 01/2009
3	Interleukin-5 (Interleukin 5)IBA 01/2014 - 01/2009
2	Biomarkers (Surrogate Marker)IBA 04/2022 - 12/2021
2	InterleukinsIBA 01/2022 - 01/2010
2	Interleukin-33IBA 01/2022 - 01/2019
2	CollagenIBA 12/2021 - 04/2005
2	LigandsIBA 06/2015 - 06/2007
2	Interleukin-4 (Interleukin 4)IBA 01/2014 - 01/2009
2	Immunoglobulin G (IgG)IBA 01/2012 - 06/2007
2	Methacholine Chloride (Methacholine)FDA Link 04/2008 - 08/2004
2	Messenger RNA (mRNA)IBA 04/2008 - 08/2006
2	Transcription Factors (Transcription Factor)IBA 04/2008 - 02/2008
2	AcidsIBA 06/2007 - 04/2007
1	Matrix Metalloproteinases (MMPs)IBA 04/2022
1	Collagen Type I (Type I Collagen)IBA 04/2022
1	Inosine Monophosphate (IMP)IBA 04/2022
1	Peptides (Polypeptides)IBA 04/2022
1	ChemokinesIBA 01/2022
1	InflammasomesIBA 01/2022
1	GlucocorticoidsIBA 01/2022
1	Omalizumab (Xolair)FDA Link 12/2021
1	anti-IgE antibodiesIBA 12/2021
1	Chymases (Chymase)IBA 12/2021
1	LipidsIBA 01/2021
1	Interleukin-17 ReceptorsIBA 07/2020
1	Pattern Recognition ReceptorsIBA 07/2020
1	Poly I-CIBA 07/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Melanocyte-Stimulating Hormones (MSH)IBA 01/2019
1	alpha-MSHIBA 01/2019
1	type IV collagen alpha3 chain (Goodpasture antigen)IBA 11/2018
1	SolutionsIBA 01/2017
1	InterferonsIBA 01/2016
1	SmokeIBA 07/2015
1	Cytidine Monophosphate (CMP)IBA 06/2015
1	Proteasome InhibitorsIBA 01/2012
1	Immunoglobulins (Immunoglobulin)IBA 01/2012
1	Bortezomib (Velcade)FDA Link 01/2012
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2010
1	Monoclonal AntibodiesIBA 01/2010
1	AntibodiesIBA 10/2009
1	Immunoglobulin A (IgA)IBA 10/2009
1	Nerve Growth Factor (NGF)IBA 04/2009
1	Nerve Growth Factors (Neurotrophins)IBA 04/2009
1	Interleukin-9 (Interleukin 9)IBA 01/2009
1	Catalytic DNA (Deoxyribozyme)IBA 04/2008
1	resiquimodIBA 06/2007
1	Interleukin-12 (IL 12)IBA 06/2007
1	Interleukin-10 (Interleukin 10)IBA 06/2007
1	Antimicrobial PeptidesIBA 08/2006
1	beta-DefensinsIBA 08/2006
1	Aligeron (AS 2)IBA 08/2004
1	AntigensIBA 08/2004
1	Proteins (Proteins, Gene)FDA Link 08/2004

Therapy/Procedure

10	Therapeutics 04/2022 - 01/2007
2	Intranasal Administration 03/2016 - 04/2008
1	Immunomodulation 01/2010